Literature DB >> 31519311

Herceptin: A First Assault on Oncogenes that Launched a Revolution.

Charles L Sawyers1.   

Abstract

This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31519311     DOI： 10.1016/j.cell.2019.08.027

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  5 in total

Review 1.  The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis.

Authors:  Pramod Mallikarjuna; Yang Zhou; Maréne Landström
Journal:  Biomolecules       Date:  2022-04-25

2.  Investigation of HER-2 Expression an Its Correlation with Clinicopathological Parameters and Overall Survival of Esophageal Squamous Cell Carcinoma Patients.

Authors:  Mitra Heidarpour; Mehran Taheri; Ali Akhavan; Parvin Goli; Amirhosein Kefayat
Journal:  Iran J Pathol       Date:  2020-07-16

Review 3.  Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.

Authors:  Ayushi Rai; Saba Noor; Syed Ishraque Ahmad; Mohamed F Alajmi; Afzal Hussain; Hashim Abbas; Gulam Mustafa Hasan
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

4.  Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach.

Authors:  Ezgi Tulukcuoglu Guneri; Emile Lakis; Ismail Hajji; Elian Martin; Jerome Champ; Aurore Rampanou; Jean-Yves Pierga; Jean-Louis Viovy; Charlotte Proudhon; François-Clément Bidard; Stéphanie Descroix
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

5.  TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.

Authors:  Yayun Gu; Huanyao Gao; Huan Zhang; August John; Xiujuan Zhu; Suganti Shivaram; Jia Yu; Richard M Weinshilboum; Liewei Wang
Journal:  Oncogene       Date:  2022-07-21       Impact factor: 8.756
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.